Search

Your search keyword '"Sferrazza, Antonella"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Sferrazza, Antonella" Remove constraint Author: "Sferrazza, Antonella"
48 results on '"Sferrazza, Antonella"'

Search Results

1. Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study

2. WITHDRAWN: Corrigendum to “Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study” [The Lancet Regional Health – Europe 41 (2024) 100912]

3. Corrigendum to “Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study” [The Lancet Regional Health – Europe 41 (2024) 100912]

8. A pilot survey on the quality of life in respiratory rehabilitation carried out in COPD patients with severe respiratory failure: preliminary data of a novel Inpatient Respiratory Rehabilitation Questionnaire (IRRQ)

9. A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus

12. Il LES: inquadramento clinico ed epidemiologico

13. [EpiInfo as a research and teaching tool in epidemiology and statistics: strengths and weaknesses]

16. Epidemiologia e burden of disease dell’Artrite Reumatoide

17. Analisi del contesto di applicazione della tecnologia

18. Le vaccinazioni dell’adulto: la valutazione di HTA del vaccino pneumococcico 13 valente coniugato nella popolazione adulta ed anziana

19. Cost of Illness Analysis of Hemophilia A: Resources Use and Direct Costs in Italy

20. Health Technology Assessment di Advate (octocog alfa) per la profilassi del sanguinamento nei pazienti con emofilia A

21. Valutazione HTA di denosumab per il trattamento dell’osteoporosi postmenopausale

22. Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide

23. Cost of illness analysis of haemophilia A: resource use and direct costs in Italy

25. Health Technology Assessment di octocog alfa nel trattamento in profilassi dell'Emofilia A

26. I costi per le fratture osteoporotiche in Italia: cosa manca?

27. L'epidemiologia a supporto del decision-making: l'importanza della valutazione del carico di malattia nel contesto dell'HTA

29. Il valore di octocog alfa nella gestione dell'Emofilia A

30. Epidemiologia dell’emofilia a nel mondo e in Italia

31. Value of octofog alfa (Advate) in the management of Haemophilia A patients

32. L'osteoporosi in Italia: un'analisi delle risorse utilizzate

35. Quantificazione dell'impatto economico dell'emofilia A in Italia

37. Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus

38. The Prevention of Postmenopausal Osteoporotic Fractures: Results of the Health Technology Assessment of a New Antiosteoporotic Drug

39. Investigating the Synergistic Interaction of Diabetes, Tobacco Smoking, Alcohol Consumption, and Hypercholesterolemia on the Risk of Pancreatic Cancer: A Case-Control Study in Italy

43. Investigating the Synergistic Interaction of Diabetes, Tobacco Smoking, Alcohol Consumption, and Hypercholesterolemia on the Risk of Pancreatic Cancer: A Case-Control Study in Italy.

46. [Is the adjustment for case-mix optional?].

47. [Risk variability and rate variability].

48. [Prevalence of domestic accidents amongst mothers of elementary and middle school children in Sardinia (Italy)].

Catalog

Books, media, physical & digital resources